全文获取类型
收费全文 | 118243篇 |
免费 | 7176篇 |
国内免费 | 1580篇 |
专业分类
耳鼻咽喉 | 1576篇 |
儿科学 | 2966篇 |
妇产科学 | 4110篇 |
基础医学 | 18256篇 |
口腔科学 | 3603篇 |
临床医学 | 9215篇 |
内科学 | 21525篇 |
皮肤病学 | 2434篇 |
神经病学 | 7982篇 |
特种医学 | 4020篇 |
外国民族医学 | 3篇 |
外科学 | 16702篇 |
综合类 | 5207篇 |
一般理论 | 34篇 |
预防医学 | 8644篇 |
眼科学 | 2813篇 |
药学 | 10181篇 |
中国医学 | 814篇 |
肿瘤学 | 6914篇 |
出版年
2021年 | 943篇 |
2019年 | 1046篇 |
2018年 | 1611篇 |
2017年 | 1168篇 |
2016年 | 1201篇 |
2015年 | 1459篇 |
2014年 | 1884篇 |
2013年 | 2441篇 |
2012年 | 3555篇 |
2011年 | 3795篇 |
2010年 | 2284篇 |
2009年 | 2047篇 |
2008年 | 3378篇 |
2007年 | 3613篇 |
2006年 | 3596篇 |
2005年 | 3164篇 |
2004年 | 2974篇 |
2003年 | 2769篇 |
2002年 | 2626篇 |
2001年 | 6731篇 |
2000年 | 6922篇 |
1999年 | 5695篇 |
1998年 | 1829篇 |
1997年 | 1376篇 |
1996年 | 886篇 |
1995年 | 860篇 |
1992年 | 3727篇 |
1991年 | 3807篇 |
1990年 | 3548篇 |
1989年 | 3552篇 |
1988年 | 3428篇 |
1987年 | 3275篇 |
1986年 | 3090篇 |
1985年 | 2967篇 |
1984年 | 2048篇 |
1983年 | 1790篇 |
1982年 | 983篇 |
1979年 | 1908篇 |
1978年 | 1184篇 |
1977年 | 984篇 |
1976年 | 917篇 |
1975年 | 1189篇 |
1974年 | 1356篇 |
1973年 | 1412篇 |
1972年 | 1355篇 |
1971年 | 1243篇 |
1970年 | 1134篇 |
1969年 | 1113篇 |
1968年 | 1022篇 |
1967年 | 895篇 |
排序方式: 共有10000条查询结果,搜索用时 515 毫秒
21.
22.
23.
Marlen Z. Gonzalez Lane Beckes Joanna Chango Joseph P. Allen James A. Coan 《Social cognitive and affective neuroscience》2015,10(7):921-928
Neuroimaging studies using the social-exclusion paradigm Cyberball indicate increased dorsal anterior cingulate cortex (dACC) and right insula activity as a function of exclusion. However, comparatively less work has been done on how social status factors may moderate this finding. This study used the Cyberball paradigm with 85 (45 females) socio-economically diverse participants from a larger longitudinal sample. We tested whether neighborhood quality during adolescence would predict subsequent neural responding to social exclusion in young adulthood. Given previous behavioral studies indicating greater social vigilance and negative evaluation as a function of lower status, we expected that lower adolescent neighborhood quality would predict greater dACC activity during exclusion at young adulthood. Our findings indicate that young adults who lived in low-quality neighborhoods in adolescence showed greater dACC activity to social exclusion than those who lived in higher quality neighborhoods. Lower neighborhood quality also predicted greater prefrontal activation in the superior frontal gyrus, dorsal medial prefrontal cortex and the middle frontal gyrus, possibly indicating greater regulatory effort. Finally, this effect was not driven by subsequent ratings of distress during exclusion. In sum, adolescent neighborhood quality appears to potentiate neural responses to social exclusion in young adulthood, effects that are independent of felt distress. 相似文献
24.
25.
26.
27.
28.
James R. Barrett MD Victoria Rendell MD Courtney Pokrzywa MD Alexandra G. Lopez-Aguiar MD John Cannon BA George A. Poultsides MD MS Flavio Rocha MD Angelena Crown MD Eliza Beal MD Timothy Michael Pawlik MD MPH PhD Ryan Fields MD Roheena Z. Panni MD MPHS Paula Smith MD Kamran Idrees MD Clifford Cho MD Megan Beems MD Shishir Maithel MD Sharon Weber MD Daniel Erik Abbott MD 《Journal of surgical oncology》2020,121(7):1067-1073
29.
A. Nast C. Smith P.I. Spuls G. Avila Valle Z. Bata-Csörgö H. Boonen E. De Jong I. Garcia-Doval P. Gisondi D. Kaur-Knudsen S. Mahil T. Mälkönen J.T. Maul S. Mburu U. Mrowietz K. Reich E. Remenyik K.M. Rønholt P.G. Sator M. Schmitt-Egenolf M. Sikora K. Strömer O. Sundnes D. Trigos G. Van Der Kraaij N. Yawalkar C. Dressler 《Journal of the European Academy of Dermatology and Venereology》2020,34(11):2461-2498
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The first part of the guideline includes general information on the scope and purpose, health questions covered, target users and strength/limitations of the guideline. Suggestions for disease severity grading and treatment goals are provided. It presents the general treatment recommendations as well as detailed management and monitoring recommendations for the individual drugs. The treatment options discussed in this guideline are as follows: acitretin, ciclosporin, fumarates, methotrexate, adalimumab, apremilast, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, secukinumab, tildrakizumab and ustekinumab. 相似文献
30.
M. T. Ferretti J. Martinkova E. Biskup T. Benke G. Gialdini Z. Nedelska K. Rauen V. Mantua D. Religa J. Hort A. Santuccione Chadha R. Schmidt 《European journal of neurology》2020,27(6):928-943
Alzheimer’s disease (AD) is characterized by high heterogeneity in disease manifestation, progression and risk factors. High phenotypic variability is currently regarded as one of the largest hurdles in early diagnosis and in the design of clinical trials; there is therefore great interest in identifying factors driving variability that can be used for patient stratification. In addition to genetic and lifestyle factors, the individual’s sex and gender are emerging as crucial drivers of phenotypic variability. Evidence exists on sex and gender differences in the rate of cognitive deterioration and brain atrophy, and in the effect of risk factors as well as in the patterns of diagnostic biomarkers. Such evidence might be of high relevance and requires attention in clinical practice and clinical trials. However, sex and gender differences are currently seldom appreciated; importantly, consideration of sex and gender differences is not currently a focus in the design and analysis of clinical trials for AD. The objective of this position paper is (i) to provide an overview of known sex and gender differences that might have implications for clinical practice, (ii) to identify the most important knowledge gaps in the field (with a special regard to clinical trials) and (iii) to provide conclusions for future studies. This scientific statement is endorsed by the European Academy of Neurology. 相似文献